UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004484
Receipt number R000005365
Scientific Title A randomized controlled trial of early rising for patients with aneurysmal subarachnoid hemorrhage
Date of disclosure of the study information 2010/10/31
Last modified on 2014/05/05 15:50:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial of early rising for patients with aneurysmal subarachnoid hemorrhage

Acronym

A randomized controlled trial of early rising for patients with aneurysmal subarachnoid hemorrhage

Scientific Title

A randomized controlled trial of early rising for patients with aneurysmal subarachnoid hemorrhage

Scientific Title:Acronym

A randomized controlled trial of early rising for patients with aneurysmal subarachnoid hemorrhage

Region

Japan


Condition

Condition

Subarachnoid hemorrhage due to the ruptur of aneurysm

Classification by specialty

Neurosurgery Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We validate by randomized controlled trials about the effect of early rising in patients who underwent the clipping of a ruptured aneurysm with subarachnoid hemorrhage, which prevent disuse syndrome and complications of bed rest, and improve ADL independence and conscious level and accelerate the discharge of home.
Furthermore, we show the effect of early rising of cerebral vasospasm occurrence.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

1)Length of stay
2)Discharge destination
3)ADL
4)Presence of disuse syndrome

Key secondary outcomes

1)Implementing rehabilitation period
2)Length of stay
3)Discharge destination
4)Level of consciousness
5)The presence of gait acquisition
6)ADL
7)MMSE
8)Limb circumference
9)Presence of leg pain
10)Presence of orthostatic hypotension
11)Presence of urinary tract infection
12)The presence of pneumonia
13)The presence of spasm occurred (symptomatic)
14)Presence of hydrocephalus caused
15)modified Ranking Scale (mRs)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation


Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

1)As soon as possible after surgery (within approximately 4 days) to begin rehabilitation.
2)Provide basic training from day one intervention.
3)Training up the bed, sitting training, standing training, strength training in a standing position,evaluation and training of higher brain functions, ADL training.
4)Gait training after removal of the draining tube.
5)Twice a day, PT, OT interventions in these programs. One measure of 20 to 40 minutes.

Interventions/Control_2

1)As soon as possible after surgery (within approximately 4 days) to begin rehabilitation.
2)Provide basic training from day one intervention.
3)Continue even after the second day of basic training. Evaluate the higher brain functions.
4)Gait training after removal of the draining tube.
5)Twice a day, PT, OT interventions in these programs. One measure of 20 to 40 minutes.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)WFNS grade 1~4
2)Patients underwent the clipping surgery
3)Patients whose intracranial pressure is controlled
4)Patients without contraindications to heart disease exercise
5)Patients who obtained permission from doctors
6) Patients in hospital

Key exclusion criteria

1)Patients with contraindications to exercise in heart disease
2) Patients who are judged to be inappropriate for subjects from doctor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo Tsutsumi

Organization

Showa General Hospital

Division name

Neurosurgery

Zip code


Address

2-450 Tenjinchyo,Kodaira-city,Tokyo

TEL

042-461-0052

Email

k.tsutsumi-md@nifty.com


Public contact

Name of contact person

1st name
Middle name
Last name Taeko Fuchi

Organization

Showa General Hospital

Division name

Rehabilitation

Zip code


Address

2-450 Tenjinchyo,Kodaira-city,Tokyo

TEL

042-461-0052

Homepage URL


Email

reha@showa-hp.jp


Sponsor or person

Institute

Showa General Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

公立昭和病院(東京都)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 09 Month 27 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 01 Day

Last follow-up date

2013 Year 12 Month 01 Day

Date of closure to data entry

2013 Year 12 Month 01 Day

Date trial data considered complete

2013 Year 12 Month 01 Day

Date analysis concluded

2013 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 10 Month 31 Day

Last modified on

2014 Year 05 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005365


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name